KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Novartis Ag (NVS) EPS (Basic) (2016 - 2025)

Novartis Ag's EPS (Basic) history spans 15 years, with the latest figure at $0.0 for Q2 2025.

  • On a quarterly basis, EPS (Basic) rose 22.12% to $0.0 in Q2 2025 year-over-year; TTM through Mar 2026 was $0.0, a 56.61% decrease, with the full-year FY2025 number at $7.21, up 47894449.78% from a year prior.
  • EPS (Basic) hit $0.0 in Q2 2025 for Novartis Ag, down from $0.0 in the prior quarter.
  • Over the last five years, EPS (Basic) for NVS hit a ceiling of $88.03 in Q3 2023 and a floor of $0.0 in Q1 2023.
  • Historically, EPS (Basic) has averaged $9.1 across 5 years, with a median of $0.0 in 2022.
  • Biggest five-year swings in EPS (Basic): crashed 100.0% in 2021 and later skyrocketed 31977579664.3% in 2023.
  • Tracing NVS's EPS (Basic) over 5 years: stood at $6.61 in 2021, then crashed by 97.43% to $0.17 in 2022, then skyrocketed by 35.74% to $0.23 in 2023, then plummeted by 100.0% to $0.0 in 2024, then tumbled by 32.7% to $0.0 in 2025.
  • Business Quant data shows EPS (Basic) for NVS at $0.0 in Q2 2025, $0.0 in Q4 2024, and $0.0 in Q2 2024.